Jalen Hurts Likely Out for Rest of Season After Blood Clots Found in Both Lungs
Philadelphia Eagles quarterback Jalen Hurts is expected to miss the remainder of the 2026 season after a serious health update revealed deep vein thrombosis and blood clots in both lungs.
Hurts was first diagnosed with a superficial blood clot, also known as superficial vein thrombosis, in his left calf while the Eagles were in London. Despite the initial diagnosis, he played through the condition during the team’s Week 5 loss to the Jacksonville Jaguars.
Further testing and monitoring led to a more serious diagnosis: deep vein thrombosis, or DVT, along with bilateral pulmonary emboli. That means blood clots were present in both lungs.
His treatment involves anticoagulation, commonly known as blood thinners. While Hurts is taking that medication, he cannot participate in contact activities, including football. That restriction is expected to keep him off the field for the rest of the season.
Statement on the Health Status of QB Jalen Hurts from the Philadelphia Eagles and Jalen Hurts’ Agent Nicole Lynn:
Over the last few days, Jalen Hurts has received comprehensive medical evaluations by physician experts. In the interest of transparency, we are providing additional information on the diagnosis and treatment plan related to his condition.
Jalen was initially diagnosed by specialists in London with a left calf superficial vein thrombosis. After further testing and monitoring, the current diagnosis is a deep vein thrombosis, as well as bilateral pulmonary emboli. He is clinically stable and has no significant functional limitations. His treatment should only involve anticoagulation (i.e., “blood thinners”). During this time, he will not be allowed to participate in any contact activities, including football.
Jalen’s prognosis is very good, and we expect a full recovery. We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners. In the meantime, he will remain active around the team and continue to condition. More importantly, we anticipate that he will have no long-term effects. We are thinking of Jalen and looking forward to a strong recovery.
The Eagles and Hurts’ agent said he is clinically stable and has no significant functional limitations. They also said his prognosis is very good, that they expect a full recovery, and that they anticipate no long-term effects.
Although Hurts cannot take part in contact work right now, he will remain active around the team and continue conditioning. The statement says he could resume contact football activities after he is no longer taking blood thinners.
Hurts has been one of the most important players in the Eagles’ recent history. He played college football at Alabama from 2016 through 2018, starting as a freshman and winning a national championship during the 2017 season.
He transferred to Oklahoma for the 2019 season, finished as the Heisman Trophy runner-up, and led the Sooners to the College Football Playoff. Philadelphia selected him in the second round of the 2020 NFL Draft with the 53rd overall pick.
Hurts became the Eagles’ starter late in his rookie season. Since then, he has led the team to multiple playoff appearances, division titles, and two Super Bowl appearances, including a victory in Super Bowl LIX.
For now, Hurts will remain around the team and continue conditioning while he undergoes treatment and stays away from contact.
— Philadelphia Eagles (@Eagles) October 19, 2026